9 employees
Solstice Pharmaceuticals dedicated to creating the next generation of diagnostic and therapeutic ultrasound products.
2020
Solstice Pharmaceuticals B.V. raised undisclosed on July 2, 2021
Investors: Parker Laboratories Inc.